Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral multifocal chorioretinitis: a distinct clinical entity?

C W Lardenoye1, A Van der Lelij, W S de Loos

  • 1Department of Ophthalmology, F.C. Donders Institute, University Hospital Utrecht, The Netherlands.

Ophthalmology
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of conjunctival, episcleral and scleral thickness in healthy individuals using anterior segment optical coherence tomography.

Acta ophthalmologica·2023
Same author

Subconjunctival Rituximab Administration for the Treatment of Scleritis.

Ocular immunology and inflammation·2022
Same author

Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis.

Ocular immunology and inflammation·2021
Same author

Recurrences of Scleritis after Ocular Surgery.

Ocular immunology and inflammation·2021
Same author

Current insights in the pathogenesis of scleritis.

Experimental eye research·2020
Same author

Successful Tocilizumab Treatment for Scleritis.

Ocular immunology and inflammation·2019

Peripheral multifocal chorioretinitis presents with specific symptoms and visual prognosis, often linked to sarcoidosis. Early recognition is key for managing this distinct clinical entity.

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Inflammatory Eye Conditions

Background:

  • Multifocal chorioretinitis encompasses various inflammatory retinal conditions.
  • A specific subset, peripheral multifocal chorioretinitis, requires distinct characterization.
  • Understanding its clinical spectrum is crucial for patient management.

Purpose of the Study:

  • To define the clinical features of peripheral multifocal chorioretinitis.
  • To investigate associated complications and visual prognosis.
  • To explore potential links with systemic diseases, particularly sarcoidosis.

Main Methods:

  • Retrospective study design.
  • Inclusion criteria: >10 peripheral retinal lesions, no central lesions, intraocular inflammation.

Related Experiment Videos

  • Analysis of 53 patients meeting criteria from a larger uveitis cohort.

    • Main Results:

    • Predominantly affected elderly white females with bilateral involvement.
    • Common complications included cystoid macular edema (CME) and cataracts, impacting visual acuity (final mean 20/60).
    • Significant association with sarcoidosis (25% of patients) and elevated angiotensin-converting enzyme (ACE) levels (29%).

    Conclusions:

    • Peripheral multifocal chorioretinitis is identified as a distinct clinical entity.
    • Recognition is valuable due to specific symptoms, visual outcomes, and sarcoidosis association.
    • Highlights the importance of systemic evaluation in these patients.